Q04.5
Megalencephaly
Clinical Classification Guidelines
Medical Intelligence & Overview
Megalencephaly, also known as macrocephaly, is a neurological condition characterized by an abnormally large brain size. The term 'megalencephaly' specifically refers to an increased brain volume that is usually evident at birth or early childhood. This condition can be isolated with no other abnormalities or may be associated with various syndromes and developmental disorders. Recognizing and understanding megalencephaly is crucial for appropriate medical follow-up and management.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting brain development Syndromic conditions such as Bannayan-Riley-Ruvalcaba syndrome or PTEN hamartoma tumor syndrome Non-syndromic developmental anomalies Environmental factors during fetal development, although less common
Key Symptoms: Enlarged head circumference noticeable at birth or during early childhood Delayed developmental milestones, including motor skills and speech Seizures or abnormal neurological activity Poor muscle tone (hypotonia) Potential learning difficulties or intellectual disability Possible physical features associated with underlying syndromes, such as distinctive facial features
Diagnostic & Treatment
Diagnosis Path: The diagnosis of megalencephaly involves a combination of physical examination, measurement of head circumference, and neuroimaging studies. Key diagnostic steps include:
Treatment Protocols: While there is no specific cure for megalencephaly, management focuses on addressing associated conditions and supporting development. Approaches include:
Clinical Advice & FAQs
Billing Guidance
Is Q04.5 a billable ICD-10 code?
Yes, Q04.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q04.5?
Clinical documentation must specify the nature of Megalencephaly and any associated comorbidities for accurate reporting.
Cite this Clinical Reference